reference/34841843

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34841843

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1422-0067
issueIdentifier	4
pageRange	3601-
publicationName	International Journal of Molecular Sciences
startingPage	3601
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9d13b317d67da1492d5adf42f69e030b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_792af6ad23a18fa349be67a907d64eb2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ce85170d135758e25182c161fb854122 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e41626dd119568a94e53a653f75c5021 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_30e09241fb81478aab8e91bd44b92c4a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_069f3f6326d9581ef631342d731b334a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e1b0f81bb385475a9eb1a2982ff4abe8
bibliographicCitation	Torres-Ruiz S, Tormo E, Garrido-Cano I, Lameirinhas A, Rojo F, Madoz-Gúrpide J, Burgués O, Hernando C, Bermejo B, Martínez MT, Lluch A, Cejalvo JM, Eroles P. High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer. Int J Mol Sci. 2023 Feb 10;24(4). PMID: 36835014; PMCID: PMC9966352.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1312-3555 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2708-6206 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dfab973b109dfb56179830cfda2ae29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8755-8626 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2255-785X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1211-473X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7801-3560 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0441-6356 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2471-5516 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8094-4076 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ce2f6aa978016cae3f8163f81482037 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6865-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aff189420cecb0a123e57773b450f571
date	2023-02-10^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36835014 https://pubmed.ncbi.nlm.nih.gov/PMC9966352 https://doi.org/10.3390/ijms24043601
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34611 https://portal.issn.org/resource/ISSN/1422-0067
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
discusses	http://id.nlm.nih.gov/mesh/M0202877 http://id.nlm.nih.gov/mesh/M0006784
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D040321Q000378 http://id.nlm.nih.gov/mesh/D064726Q000378 http://id.nlm.nih.gov/mesh/D064726Q000188 http://id.nlm.nih.gov/mesh/D004317Q000627 http://id.nlm.nih.gov/mesh/D004317Q000494 http://id.nlm.nih.gov/mesh/D040321Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D049109 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009364
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5a10bff44321e2f4009b2e7bc13c3771 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2324

Showing number of triples: 1 to 54 of 54.